Liaoning Chengda Biotechnology Co Ltd
SSE:688739

Watchlist Manager
Liaoning Chengda Biotechnology Co Ltd Logo
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Watchlist
Price: 26.71 CNY -4.02% Market Closed
Market Cap: 4.9B CNY
Have any thoughts about
Liaoning Chengda Biotechnology Co Ltd?
Write Note

Liaoning Chengda Biotechnology Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Liaoning Chengda Biotechnology Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Liaoning Chengda Biotechnology Co Ltd
SSE:688739
Interest Income Expense
ÂĄ106m
CAGR 3-Years
5%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-ÂĄ59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
ÂĄ217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Interest Income Expense
-ÂĄ8.1m
CAGR 3-Years
N/A
CAGR 5-Years
58%
CAGR 10-Years
9%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-ÂĄ45.8m
CAGR 3-Years
27%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
ÂĄ78.6m
CAGR 3-Years
37%
CAGR 5-Years
99%
CAGR 10-Years
N/A
No Stocks Found

Liaoning Chengda Biotechnology Co Ltd
Glance View

Market Cap
4.9B CNY
Industry
Biotechnology

Liaoning Chengda Biotechnology Co., Ltd. is engaged in the research, development, manufacture and sale of vaccines. The company is headquartered in Shenyang, Liaoning and currently employs 1,663 full-time employees. The company went IPO on 2021-10-28. The firm's main products include rabies vaccine for human use, freeze-dried rabies vaccine for human use, inactivated Japanese encephalitis vaccine for human use and freeze-dried encephalitis inactivated vaccine. The firm's products include two brands: Chengda Suda and Chengda Libao.

Intrinsic Value
34.95 CNY
Undervaluation 24%
Intrinsic Value
Price

See Also

What is Liaoning Chengda Biotechnology Co Ltd's Interest Income Expense?
Interest Income Expense
106m CNY

Based on the financial report for Dec 31, 2023, Liaoning Chengda Biotechnology Co Ltd's Interest Income Expense amounts to 106m CNY.

What is Liaoning Chengda Biotechnology Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
16%

Over the last year, the Interest Income Expense growth was 23%. The average annual Interest Income Expense growth rates for Liaoning Chengda Biotechnology Co Ltd have been 5% over the past three years , 16% over the past five years .

Back to Top